| |
| |
|
| Insider
Information: |
Biondi Paul |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
53,833 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$317,984 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
53,833 |
|
|
| Total
Value |
$317,984 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP, Head of Strategy ... |
2019-10-02 |
6,214 |
2018-07-01 |
0 |
Premium* |
|
|
Seres Therapeutics, Inc. |
MCRB |
Director |
2022-07-05 |
47,619 |
2022-07-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCRB |
Seres Therapeutics, Inc. |
Director |
– • – |
2022-07-05 |
4 |
A |
$3.15 |
$150,000 |
D/D |
47,619 |
47,619 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2019-10-02 |
4 |
D |
$49.21 |
$9,990 |
D/D |
(203) |
6,214 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2019-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
592 |
6,417 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2019-03-10 |
4 |
D |
$51.39 |
$163,831 |
D/D |
(3,188) |
5,825 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,619 |
7,860 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(647) |
3,050 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4 |
D |
$62.80 |
$18,338 |
D/D |
(292) |
300 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4/A |
OE |
$0.00 |
$0 |
D/D |
592 |
1,333 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4/A |
D |
$62.80 |
$18,338 |
D/D |
(292) |
1,041 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
592 |
592 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-07-01 |
4 |
D |
$55.34 |
$39,845 |
D/D |
(720) |
741 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Head of Strategy & BD |
• – – |
2018-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,461 |
1,461 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
